Metis Global Partners, LLC Merck & Co., Inc. Transaction History
Metis Global Partners, LLC
- $3.48 Billion
- Q1 2025
A detailed history of Metis Global Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Metis Global Partners, LLC holds 168,036 shares of MRK stock, worth $13 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
168,036
Previous 152,072
10.5%
Holding current value
$13 Million
Previous $15.1 Million
0.3%
% of portfolio
0.43%
Previous 0.47%
Shares
14 transactions
Others Institutions Holding MRK
# of Institutions
3,891Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.3 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.3 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.6 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...